fintopic.
Docs Get the API

Piramal Pharma Q2 FY27 profitability surge

11 statements from 4 sources, Oct 27, 2026 17:34 UTC to Oct 29, 2026 12:26 UTC
News
Updated
PPLPHARMA.NS
Front page

Statements (10 of 11)

  1. Bullish

    Piramal Pharma recorded a monthly gain of 12%.

    economictimes.indiatimes.com
  2. Bullish

    Piramal Pharma reported a 15% increase in stock price following its Q2 results.

    business-standard.com
  3. Bullish

    Piramal Pharma expects meaningfully higher profitability

    cnbctv18.comHigh importance
  4. Bullish

    Piramal Pharma shares surge 14% as Q2 profitability improves

    cnbctv18.comHigh importance
  5. Bullish

    Piramal Pharma upgrades FY27 revenue growth outlook to 19%-20%

    cnbctv18.comHigh importance
  6. Neutral

    Piramal Pharma Limited reported results for the second quarter and first half of fiscal year 2027

    prnewswire.comHigh importance
  7. Neutral

    Piramal Pharma Limited reported results for the second quarter and half year ended September 30, 2026

    prnewswire.comHigh importance
  8. Bullish

    Piramal Pharma reported a net profit of ₹5.58 crore in Q2 FY27, up from a loss of ₹99.2 crore the previous year.

    cnbctv18.comHigh importance
  9. Bullish

    Piramal Pharma upgraded its FY27 revenue growth outlook to 19%–20%.

    cnbctv18.comHigh importance
  10. Bullish

    Piramal Pharma's revenue grew 28% to ₹2,617 crore in Q2 FY27.

    cnbctv18.comHigh importance

1 more statement on this development this week. The API returns all of them: GET /v2/statements?topic_id=549162fd-5103-4fda-b6aa-a3b61c9b8f04 Get a free API key ↗